InVivo Therapeutics' neuro-spinal scaffold device is designed to reduce paralysis symptoms resulting from acute spinal cord injury, according to MoneyShow.
Here are five observations:
1. The scaffold has already been designated as a Humanitarian Use Device, which speeds the approval process.
2. InVivo is currently conducting a clinical study, INSPIRE, to test the device on patients with complete acute thoracic SCI.
3. InVivo plans to also conduct trials on cervical spine injuries later this year. The company wants to combine neural stem cells with a hydrogel to inject stem cell trails across SCI.
4. Based on the trials' successes so far, InVivo is set for final approval in about two years.
5. InVivo's stock has improved, as investors notice the company's potential.